Adam is currently a lecturer whose research focusses on the interactions of biomaterials with the immune system. Adam obtained a PhD in Vaccinology from University of Surrey under the supervision of Dr Simon Graham and Prof. Graham Stewart. This research was on development of particulate based systems as novel immune adjuvants as well as delivery vehicles for vaccines. He then worked at Imperial College London, Department of Mucosal Immunology under Dr John Tregoning in partnership with an industrial collaborator. The project was looking at novel DNA vaccine formulations for induction of humoral and cellular immune responses in numerous models. Following this Adam had a 5-year stint as a Research Associate at the Jenner Institute, University of Oxford, investigating controlled delivery of antigen for induction of spatially and temporally restricted immune responses, primarily for malaria working with Dr Anita Milicic and Prof. Adrian Hill. Joining Professor Khuloud Al-Jamal’s team at KCL, Adam moved from infectious disease to the assessment of nanostructures for use in prophylactic and therapeutic cancer treatments. Adam was awarded the prestigious Maplethorpe fellowship (2019-2022) to work on particulate formulations for nucleic acid delivery to tumours. He continued this work at AstraZeneca (2022-2024) but has now returned to King’s College London to take up his current role.